Clinical Hematology International

ISSN (Online):
2590-0048
ISSN (Print):
N/A
Editor(s)-in-Chief:

Mohamad Mohty, Arnon Nagler, Bipin Savani

Indexed in:
  • Directory of Open Access Journals (DOAJ)
  • Subject: PMC
  • General: Ulrichsweb, Google Scholar
  • Local: CNKI, Wanfang Data

Following the acquisition of Atlantis Press by Springer Nature, this journal has moved to SpringerLink. Please refer to the new journal homepage here for more information. This page also contains a link to the new submission system. Already published content will remain available on the Atlantis Press platform until further notice and will be migrated to SpringerLink in due course.

Clinical Hematology International is the official journal of the International Academy for Clinical Hematology (IACH). Publishing services are provided by Atlantis Press on behalf of IACH which owns the copyright to the journal. Peer review is under the responsibility of IACH.

The journal publishes articles in the broad field of clinical hematology, reporting on novel findings in clinical and translational research and covering topics such as benign & malignant hematology, hematopoietic cell transplantation and cellular therapy. Read full Aims & Scope

Clinical Hematology International is an open access journal, i.e. all articles are immediately and permanently free to read, download, copy & distribute. The journal is published under the CC BY-NC 4.0 user license which defines the permitted 3rd-party reuse of its articles. Publication in this journal is free of charge for Authors. All open access publication fees are subsidized by the International Academy for Clinical Hematology (IACH). Note that this is a promotional offer which applies to all papers submitted before 31 December 2021.

NOTE: For any updates on APC pricing, please refer to the new journal homepage here. For details on eligibility for APC waivers or discounts, please refer to the Springer Nature policies here for more information.

For any questions about this publication, please contact our publishing team.

Journal Metrics

Impact Factor
N/A
5-Year Impact Factor
N/A
Immediacy Index
N/A
CiteScore
N/A
Source-Normalized Impact/Paper
N/A
SCImago Journal Rank
N/A
Field-Weighted Citation Impact
N/A
Eigenfactor
N/A
Article Influence
N/A
Total Citations (Scopus data)
149
Cited Half-Life
N/A
Citing Half-Life
N/A
Total Downloads
20,696
Average Publication Speed
12.5 weeks
Acceptance Rate
51.4%

How I Use Measurable Residual Disease in the Clinical Management of Adult Acute Lymphoblastic Leukemia

Fiona Fernando, Harry Frederick Robertson, Sarah El-Zahab, Jiří Pavlů
Volume 3, Issue 4, December 2021, Pages 130-141

The Management of a Comprehensive Cancer Center during the First Six Months of the COVID-19 Pandemic in the South of France: Lessons from the Paoli-Calmettes Institute’s Experience

Didier Blaise, Pierre Berger, Djamel Mokart, Jacques Camerlo, Emmanuelle Fougereau, Marc Giovannini, Gilles Houvenaeghel, Olivier Turrini, Christian Chabannon, Gilles Piana, Isabelle Brenot-Rossi, Agnès Tallet, Anthony Gonçalves, Aude Charbonnier, Norbert Vey, Sabrina Grossi, Patrice Viens
Volume 3, Issue 4, December 2021, Pages 119-129

Gastrointestinal Complications after Allogeneic Hematopoietic Stem Cell Transplant: A Multidisciplinary Approach with Early Endoscopic Evaluation

Giuseppe Tarantino, Francesco Saraceni, Giorgia Mancini, Monica Poiani, Luca Maroni, Gaia Goteri, Ilaria Scortechini, Alessandro Fiorentini, Maria Vittoria Dubbini, Francesco Marini, Luigi Daretti, Marco Marzioni, Emanuele Bendia, Antonio Benedetti, Attilio Olivieri
Volume 3, Issue 4, December 2021, Pages 161-168

View More Latest Articles